EastPharma
EastPharma is a pharmaceutical company specializing in the manufacturing and marketing of branded and in-licensed generic pharmaceuticals in Turkey and other regional markets. Established in 2006, it controls Deva Holding, one of Turkey’s leading pharmaceutical companies, and has expanded through acquisitions and strategic partnerships. The company focuses on R&D, high-quality production, and global market presence, with a mission to be a leading branded generic pharmaceutical company in Turkey and the region, and a vision to become a consolidation platform for pharma companies in Turkey and emerging markets.
Industries
Nr. of Employees
Very Large (1000+)
EastPharma
Products
Generic pharmaceutical products and finished dosage forms
Branded generics and in‑licensed generic medicines across multiple therapeutic areas produced as tablets, injectables, inhalers, ampoules and veterinary formulations.
Active pharmaceutical ingredients (APIs)
Manufacture and supply of selected APIs produced at a dedicated facility acquired to support internal manufacturing and external sales/licensing.
Generic pharmaceutical products and finished dosage forms
Branded generics and in‑licensed generic medicines across multiple therapeutic areas produced as tablets, injectables, inhalers, ampoules and veterinary formulations.
Active pharmaceutical ingredients (APIs)
Manufacture and supply of selected APIs produced at a dedicated facility acquired to support internal manufacturing and external sales/licensing.
Services
Manufacturing, quality control and commercialization of generic formulations and finished pharmaceutical products for domestic and international markets.
In‑house research and development for new generic formulations, stability and method development to transfer products to commercial production.
Management of product registration processes and distribution in multiple countries supported by a network of regional subsidiaries and affiliates.
Manufacturing, quality control and commercialization of generic formulations and finished pharmaceutical products for domestic and international markets.
In‑house research and development for new generic formulations, stability and method development to transfer products to commercial production.
Management of product registration processes and distribution in multiple countries supported by a network of regional subsidiaries and affiliates.
Expertise Areas
- Generic drug development and manufacturing
- API production and licensing
- Sterile injectables and inhalation product manufacturing
- Regulatory affairs and international registrations (ANDA, national authorities)
Key Technologies
- Formulation development for generics
- Active pharmaceutical ingredient (API) synthesis and scale-up
- Sterile injectables manufacturing
- Inhalation product manufacturing
News & Updates
Details and documents related to the 2023 AGM.
Details and documents related to the 2022 AGM.
A message from the Chairman highlighting the company's performance and future outlook for 2024.
Overview of EastPharma's growth strategy and market position.
Recognized as the pharmaceutical company with the highest R&D expenditure in Turkey in 2024.
Details and documents related to the 2023 AGM.
Details and documents related to the 2022 AGM.
A message from the Chairman highlighting the company's performance and future outlook for 2024.
Overview of EastPharma's growth strategy and market position.
Recognized as the pharmaceutical company with the highest R&D expenditure in Turkey in 2024.